What we now know about NMN and longevity — a review of human studies
NMN, a precursor of NAD+, has for years been one of the most hotly debated supplements in the biohacking community. We look at what the latest clinical trials in humans show, as distinct from earlier studies in mice.
Table of contents
TL;DR — key takeaways
- →Why NMN generates so much interest in the first place
- →What one of the first well-controlled human studies showed
- →A second important study: effects on muscle function in older men
- →What still remains unknown
- →What about nicotinamide riboside (NR) — an alternative NAD+ precursor
- →Table: what we know, and what we still don't
- →Our editorial recommendation








